Browsing Tag

Test Update

Referral/Sendouts, Southeast Michigan, Southwest Michigan, West Michigan

Primary Reference Lab Change to Quest Diagnostics

Effective November 19, 2025

Corewell Health Laboratory is transitioning to Quest Diagnostics as our primary reference testing laboratory. This change means that nearly all referral and send-out tests will now be performed by Quest Diagnostics. A limited number of tests will continue to be sent to other laboratories to ensure we meet the needs of our patients and clinicians.

What You Need to Know:

  • Test Crosswalks: Tests currently performed at ARUP and Mayo Clinic Labs will be matched to comparable tests at Quest Diagnostics.
  • Discontinued Tests: Tests with low utilization or those no longer deemed clinically necessary will be discontinued.
  • New LAB Numbers: All tests will receive new LAB numbers, which must be updated in your EMR compendium if interfaced.
  • Collection Devices: Some tests may require different collection devices.
  • Transition Timeline:
    • November 19, 2025: Focus on tests currently referred to ARUP.
    • December 17, 2025: Focus on tests currently referred to Mayo Clinic Labs.
  • Crosswalk Resources: Crosswalks between current and future test offerings will be provided to help you prepare.
  • Test Directory Access: Please refer to your regional Lab Test Directory for details on specific test changes. ARUP and Mayo Clinic Lab test pages will include links to the corresponding Quest Diagnostic tests.

We understand the significance of these changes and are committed to supporting your practice throughout this transition. Updates and modifications will be communicated promptly.

Contact Information:

  • Corewell Health East Sendouts: 248.551.9045
  • Corewell Health West Referrals: 616.267.2753
  • Or use the Contact Us link above.
October 27, 2025 by
General Information

MRSA PCR: Updated indications for ordering

Effective Date: September 3, 2025

The MRSA Screen PCR [LAB1231076] detects the presence or absence of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and may be used to guide antimicrobial prophylaxis decisions. To improve and standardize test utilization across all Corewell Health regions, the following restrictions will be added to this test order:

  • Ordering will be restricted to one test every 7 days.
  • An indication for ordering must be provided for each order. Acceptable indications are:
    • Pneumonia
    • Skin and soft tissue (use for non-purulent infections)
    • Surgical prophylaxis

Studies have shown that there is minimal utility in re-testing within 2 weeks as MRSA conversion rates are low and the PCR negative predictive values remain high for at least 14 days after initial testing.

Absence of nasal colonization with MRSA cannot be used to reliably rule out MRSA infection in scenarios other than those listed above.

Test Information

MRSA Screen PCR [LAB1231076]

August 20, 2025 by
Hematology

Hematology Testing Updates (Corewell Health West Michigan)

Effective Wednesday, July 30, 2025, changes to result reporting will be implemented across all Hematology Departments at Corewell Health Laboratories. These updates will help align all regions within Corewell Health Hematology Departments to provide a high-quality and standardize patient care experience.

The following are the most impactful changes for the Corewell Health West Michigan Region: Continue Reading

July 18, 2025 by
General Information

Test Update: PD-L1

Effective July 30, 2025, PD-L1 testing will be performed at Corewell Health Reference Laboratory East and will no longer be a sendout to Neogenomics. Collection instructions and other information may have changed, please visit the lab catalog for more information.

For questions and inquiries, please use the “Contact Us” link above.

 

TEST INFORMATION

New test: PD-L1 [LAB3658]

Former test: PD-L1 to Neogenomics (LAB848)

July 18, 2025 by